Cargando…

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease

PURPOSE: Sinonasal symptoms are prevalent in COPD, and knowledge of the relationship between these symptoms and clinical markers of COPD is limited. This study explores the associations between the burden of sinonasal symptoms and clinical markers and thresholds recommended for guiding treatment dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Øie, Marte Rystad, Helvik, Anne-Sofie, Sue-Chu, Malcolm, Steinsvåg, Sverre Karmhus, Thorstensen, Wenche Moe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464443/
https://www.ncbi.nlm.nih.gov/pubmed/36101792
http://dx.doi.org/10.2147/COPD.S372991
_version_ 1784787583131189248
author Øie, Marte Rystad
Helvik, Anne-Sofie
Sue-Chu, Malcolm
Steinsvåg, Sverre Karmhus
Thorstensen, Wenche Moe
author_facet Øie, Marte Rystad
Helvik, Anne-Sofie
Sue-Chu, Malcolm
Steinsvåg, Sverre Karmhus
Thorstensen, Wenche Moe
author_sort Øie, Marte Rystad
collection PubMed
description PURPOSE: Sinonasal symptoms are prevalent in COPD, and knowledge of the relationship between these symptoms and clinical markers of COPD is limited. This study explores the associations between the burden of sinonasal symptoms and clinical markers and thresholds recommended for guiding treatment decisions in the GOLD guidelines. PATIENTS AND METHODS: Sinonasal symptoms were quantified with the rhinological subscale of the Sino-Nasal-Outcome-Test (SNOT-22) in 93 COPD patients characterized by the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2012 diagnostic criteria for rhinosinusitis without nasal polyps (RSsNP). Associations between a high burden, defined as a SNOT22_rhinological score of ≥11, and the following markers were assessed by adjusted multivariable linear regressions; severity of dyspnea [modified Medical Research Council (mMRC)] and cough [Visual Analogue Scale (VAS)], physical activity [6-minute walking distance (6MWD)], mortality risk (BODE index), and HRQoL [disease-specific COPD Assessment Test (CAT) and St. Georges Respiratory Questionnaire (SGRQ), and physical component summary, Short Form-36 version 2.0 (PCS SF-36v2)]. Odds ratios for the association of a high burden and threshold levels for regular treatment were estimated by adjusted binomial logistic regression models. RESULTS: A high burden was associated with greater severity of dyspnea and cough, lower 6MWD, higher BODE index and poorer HRQoL. The odds ratio of having CAT and SGRQ scores that are above the thresholds recommended for treatment was 5–7-fold greater in the high burden group. CONCLUSION: A high burden of sinonasal symptoms is positively associated with the clinical markers of symptom severity and mortality risk and is inversely associated with physical activity and HRQoL in COPD. These findings add further support that the UAD concept also applies to COPD. Enquiry about sinonasal symptoms in COPD patients should be incorporated into the clinical routine.
format Online
Article
Text
id pubmed-9464443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94644432022-09-12 Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease Øie, Marte Rystad Helvik, Anne-Sofie Sue-Chu, Malcolm Steinsvåg, Sverre Karmhus Thorstensen, Wenche Moe Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Sinonasal symptoms are prevalent in COPD, and knowledge of the relationship between these symptoms and clinical markers of COPD is limited. This study explores the associations between the burden of sinonasal symptoms and clinical markers and thresholds recommended for guiding treatment decisions in the GOLD guidelines. PATIENTS AND METHODS: Sinonasal symptoms were quantified with the rhinological subscale of the Sino-Nasal-Outcome-Test (SNOT-22) in 93 COPD patients characterized by the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2012 diagnostic criteria for rhinosinusitis without nasal polyps (RSsNP). Associations between a high burden, defined as a SNOT22_rhinological score of ≥11, and the following markers were assessed by adjusted multivariable linear regressions; severity of dyspnea [modified Medical Research Council (mMRC)] and cough [Visual Analogue Scale (VAS)], physical activity [6-minute walking distance (6MWD)], mortality risk (BODE index), and HRQoL [disease-specific COPD Assessment Test (CAT) and St. Georges Respiratory Questionnaire (SGRQ), and physical component summary, Short Form-36 version 2.0 (PCS SF-36v2)]. Odds ratios for the association of a high burden and threshold levels for regular treatment were estimated by adjusted binomial logistic regression models. RESULTS: A high burden was associated with greater severity of dyspnea and cough, lower 6MWD, higher BODE index and poorer HRQoL. The odds ratio of having CAT and SGRQ scores that are above the thresholds recommended for treatment was 5–7-fold greater in the high burden group. CONCLUSION: A high burden of sinonasal symptoms is positively associated with the clinical markers of symptom severity and mortality risk and is inversely associated with physical activity and HRQoL in COPD. These findings add further support that the UAD concept also applies to COPD. Enquiry about sinonasal symptoms in COPD patients should be incorporated into the clinical routine. Dove 2022-09-07 /pmc/articles/PMC9464443/ /pubmed/36101792 http://dx.doi.org/10.2147/COPD.S372991 Text en © 2022 Øie et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Øie, Marte Rystad
Helvik, Anne-Sofie
Sue-Chu, Malcolm
Steinsvåg, Sverre Karmhus
Thorstensen, Wenche Moe
Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
title Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
title_full Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
title_fullStr Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
title_full_unstemmed Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
title_short Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
title_sort sinonasal symptoms in copd: burden and associations with clinical markers of disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464443/
https://www.ncbi.nlm.nih.gov/pubmed/36101792
http://dx.doi.org/10.2147/COPD.S372991
work_keys_str_mv AT øiemarterystad sinonasalsymptomsincopdburdenandassociationswithclinicalmarkersofdisease
AT helvikannesofie sinonasalsymptomsincopdburdenandassociationswithclinicalmarkersofdisease
AT suechumalcolm sinonasalsymptomsincopdburdenandassociationswithclinicalmarkersofdisease
AT steinsvagsverrekarmhus sinonasalsymptomsincopdburdenandassociationswithclinicalmarkersofdisease
AT thorstensenwenchemoe sinonasalsymptomsincopdburdenandassociationswithclinicalmarkersofdisease